2021
Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congress
Dec 3, 2021
Read More
Marizyme Announces New Distribution and Channel Partnership for Chilean Market with Abdera
Mar 04, 2021
Read More
Marizyme Announces the Use of DuraGraft® as the Standard-of-Care in Patients Undergoing Coronary Artery Bypass Surgery (CABG) at Vienna Heart Center North Floridsdorf
Jan 11, 2021
Read More
Marizyme, Inc. to Present at Biotech Showcase 2021 During the J.P. Morgan Healthcare Conference Biotech Showcase Digital, BIO @ JPM During “J.P. Morgan Week 2021”
Jan 07, 2021
Read More
2020
Univest Securities, LLC. Announces Closing of Somulation, Inc. Acquisition and $7 Million Private Placement for its Client Marizyme, Inc.
Sep 29, 2020
Read More
Marizyme, Inc. Completes Acquisition of Somahlution, Inc. and Raises
$7.0 Million in Private
Placement
Sep 29, 2020
Read More
Marizyme, Inc., Engages Dr. Pamela
Milla as Advisor to Begin
Distribution in South
America
Apr 26, 2020
Read More